125 related articles for article (PubMed ID: 37658729)
1. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia.
Law CK; Cust AE; Smit AK; Trevena L; Fernandez-Penas P; Nieweg OE; Menzies AM; Wordsworth S; Morton RL;
Genet Med; 2023 Dec; 25(12):100970. PubMed ID: 37658729
[TBL] [Abstract][Full Text] [Related]
2. The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
Smit AK; Newson AJ; Morton RL; Kimlin M; Keogh L; Law MH; Kirk J; Dobbinson S; Kanetsky PA; Fenton G; Allen M; Butow P; Dunlop K; Trevena L; Lo S; Savard J; Dawkins H; Wordsworth S; Jenkins M; Mann GJ; Cust AE
Contemp Clin Trials; 2018 Jul; 70():106-116. PubMed ID: 29802966
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
4. Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use.
Hirst NG; Gordon LG; Scuffham PA; Green AC
Value Health; 2012; 15(2):261-8. PubMed ID: 22433757
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.
Chowdhury EK; Reid CM; Zomer E; Kelly DJ; Liew D
Am J Hypertens; 2018 Sep; 31(10):1156-1163. PubMed ID: 30010694
[TBL] [Abstract][Full Text] [Related]
6. The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.
Lo SN; Smit AK; Espinoza D; Cust AE;
Trials; 2020 Jun; 21(1):594. PubMed ID: 32605576
[TBL] [Abstract][Full Text] [Related]
7. Are weekend inpatient rehabilitation services value for money? An economic evaluation alongside a randomized controlled trial with a 30 day follow up.
Brusco NK; Watts JJ; Shields N; Taylor NF
BMC Med; 2014 May; 12():89. PubMed ID: 24885811
[TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia.
Vu M; Degeling K; Thompson ER; Blombery P; Westerman D; IJzerman MJ
Appl Health Econ Health Policy; 2024 Jan; 22(1):107-122. PubMed ID: 37608228
[TBL] [Abstract][Full Text] [Related]
9. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.
Zhao R; Fairley CK; Cook AR; Phanuphak N; He S; Tieosapjaroen W; Chow EPF; Phillips TR; Jin Tan RK; Wei Y; Shen M; Zhuang G; Ong JJ; Zhang L
Lancet Glob Health; 2024 Feb; 12(2):e243-e256. PubMed ID: 38245115
[TBL] [Abstract][Full Text] [Related]
10. Offering a lifestyle intervention to women of premenopausal age as primary prevention for cardiovascular disease? - assessing its cost-effectiveness.
Gao L; Moodie M
Int J Behav Nutr Phys Act; 2022 Dec; 19(1):152. PubMed ID: 36517831
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.
Dieng M; Khanna N; Kasparian NA; Costa DSJ; Butow PN; Menzies SW; Mann GJ; Cust AE; Morton RL
Appl Health Econ Health Policy; 2019 Oct; 17(5):669-681. PubMed ID: 31228015
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing.
Doble B; John T; Thomas D; Fellowes A; Fox S; Lorgelly P
Lung Cancer; 2017 May; 107():22-35. PubMed ID: 27316470
[TBL] [Abstract][Full Text] [Related]
13. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
Marklund M; Zheng M; Veerman JL; Wu JHY
PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.
Zhou J; Liew D; Kaye DM; Zoungas S; Stub D
Circ Cardiovasc Qual Outcomes; 2022 Oct; 15(10):e008638. PubMed ID: 36252135
[TBL] [Abstract][Full Text] [Related]
15. Are Office-Based Workplace Interventions Designed to Reduce Sitting Time Cost-Effective Primary Prevention Measures for Cardiovascular Disease? A Systematic Review and Modelled Economic Evaluation.
Gao L; Nguyen P; Dunstan D; Moodie M
Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30866495
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of an incentive-based program to increase physical activity and reduce sedentary behaviour in middle-aged adults.
Maple JL; Ananthapavan J; Ball K; Teychenne M; Moodie M
BMC Health Serv Res; 2022 Jul; 22(1):932. PubMed ID: 35854379
[TBL] [Abstract][Full Text] [Related]
17. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
Zhang L; Bao Y; Riaz M; Tiller J; Liew D; Zhuang X; Amor DJ; Huq A; Petelin L; Nelson M; James PA; Winship I; McNeil JJ; Lacaze P
Genet Med; 2019 Sep; 21(9):1958-1968. PubMed ID: 30773532
[TBL] [Abstract][Full Text] [Related]
18. Cost Effectiveness of Falls and Injury Prevention Strategies for Older Adults Living in Residential Aged Care Facilities.
Church JL; Haas MR; Goodall S
Pharmacoeconomics; 2015 Dec; 33(12):1301-10. PubMed ID: 26242882
[TBL] [Abstract][Full Text] [Related]
19. Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study.
Gordon L; Olsen C; Whiteman DC; Elliott TM; Janda M; Green A
BMJ Open; 2020 Feb; 10(2):e034388. PubMed ID: 32107270
[TBL] [Abstract][Full Text] [Related]
20. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
